- Home
- PFL
as 12-18-2024 12:41pm EST
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 326.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 113.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $6.98 - $8.62 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest PIMCO Income Strategy Fund Shares of Beneficial Interest News
PFL Breaking Stock News: Dive into PFL Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
GlobeNewswire
2 months ago
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
GlobeNewswire
3 months ago
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
GlobeNewswire
3 months ago
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
GlobeNewswire
5 months ago
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
GlobeNewswire
6 months ago
PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Yahoo Finance Video
6 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
6 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Compare PFL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PFL PIMCO Income Strategy Fund Shares of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.